EquityZen Growth Technology Fund LLC - Series 1018
Raised
$799K
Investors
41
Min Invest
$10,002
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1018 is a Delaware-organized pooled investment vehicle filed by EquityZen Advisors LLC and affiliates on 2021-12-01. The fund raised $799K from 41 investors with a $10K minimum investment, relying on Regulation D Rule 506(b) and Investment Company Act Section 3(c)(1) exemptions. This is one of approximately 1,889 related entities on the EquityZen pre-IPO investment platform.
This offering is typical of EquityZen's serialized SPV model for pre-IPO secondary share access, using the standard 506(b)/3(c)(1) exemption pairing and a $10K minimum that enables retail accredited investor participation. The $799K raise and 41-investor count reflect a democratized investment structure common to pre-IPO platform vehicles targeting single-company exposure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
